Yohn Christine N, Gergues Mark M, Samuels Benjamin Adam
Department of Psychology, Behavioral & Systems Neuroscience Area, Rutgers, The State University of New Jersey, 152 Frelinghuysen Rd., Room 215, Piscataway, NJ, 08816, USA.
Mol Brain. 2017 Jun 24;10(1):28. doi: 10.1186/s13041-017-0306-y.
Depression is a polygenic and highly complex psychiatric disorder that remains a major burden on society. Antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), are some of the most commonly prescribed drugs worldwide. In this review, we will discuss the evidence that links serotonin and serotonin receptors to the etiology of depression and the mechanisms underlying response to antidepressant treatment. We will then revisit the role of serotonin in three distinct hypotheses that have been proposed over the last several decades to explain the pathophysiology of depression: the monoamine, neurotrophic, and neurogenic hypotheses. Finally, we will discuss how recent studies into serotonin receptors have implicated specific neural circuitry in mediating the antidepressant response, with a focus being placed on the hippocampus.
抑郁症是一种多基因且高度复杂的精神障碍,仍然是社会的一项重大负担。抗抑郁药,如选择性5-羟色胺再摄取抑制剂(SSRI),是全球最常用的处方药之一。在这篇综述中,我们将讨论将血清素和血清素受体与抑郁症病因联系起来的证据,以及对抗抑郁治疗反应的潜在机制。然后,我们将重新审视血清素在过去几十年中提出的三种不同假说来解释抑郁症病理生理学中的作用:单胺假说、神经营养假说和神经发生假说。最后,我们将讨论最近对血清素受体的研究如何表明特定神经回路在介导抗抑郁反应中的作用,重点是海马体。